GB2276170B
(en)
*
|
1993-02-17 |
1997-04-16 |
British Tech Group |
Polymers containing guanidine groups for use in therapy
|
US5487888A
(en)
*
|
1993-05-20 |
1996-01-30 |
Geltex, Inc. |
Iron-binding polymers for oral administration
|
US5667775A
(en)
*
|
1993-08-11 |
1997-09-16 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
GB9503061D0
(en)
*
|
1995-02-16 |
1995-04-05 |
British Tech Group |
Polymeric compounds
|
DE19528524C2
(de)
*
|
1995-08-03 |
1999-11-11 |
Hans Dietl |
Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
|
ES2162658T3
(es)
*
|
1996-03-05 |
2002-01-01 |
Mitsubishi Chem Corp |
Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia.
|
CN1230118A
(zh)
*
|
1996-07-19 |
1999-09-29 |
日研化学株式会社 |
高磷血症治疗剂
|
AU735056B2
(en)
*
|
1996-10-23 |
2001-06-28 |
Dow Chemical Company, The |
Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
|
AU2446497A
(en)
*
|
1997-03-25 |
1998-10-20 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers combined with a calcium supplement for oral administration
|
TW592727B
(en)
*
|
1997-04-04 |
2004-06-21 |
Chugai Pharmaceutical Co Ltd |
Phosphate-binding polymer preparations
|
US6423754B1
(en)
*
|
1997-06-18 |
2002-07-23 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with polyallylamine polymers
|
NZ516848A
(en)
*
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
US6566407B2
(en)
|
1997-11-05 |
2003-05-20 |
Geltex Pharmaceuticals, Inc. |
Method for reducing oxalate
|
US6726905B1
(en)
|
1997-11-05 |
2004-04-27 |
Genzyme Corporation |
Poly (diallylamines)-based phosphate binders
|
US5985938A
(en)
*
|
1997-11-05 |
1999-11-16 |
Geltex Pharmaceuticals, Inc. |
Method for reducing oxalate
|
AU2682499A
(en)
*
|
1998-02-17 |
1999-08-30 |
Dimitri R. Kioussis |
Anion binding polymers and the use thereof
|
AU3005599A
(en)
*
|
1998-03-19 |
1999-10-11 |
Geltex Pharmaceuticals, Inc. |
Continuous crosslinking of polymer gels
|
US6294163B1
(en)
|
1998-10-02 |
2001-09-25 |
Geltex Pharmaceuticals, Inc. |
Polymers containing guanidinium groups as bile acid sequestrants
|
JP4749649B2
(ja)
*
|
1998-10-12 |
2011-08-17 |
中外製薬株式会社 |
リン酸結合性ポリマー
|
TW568788B
(en)
*
|
1998-10-12 |
2004-01-01 |
Chugai Pharmaceutical Co Ltd |
Polymer combining with phosphoric acid and preparation containing the same
|
US6271264B1
(en)
|
1998-12-01 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
|
DE60035414T2
(de)
*
|
1999-04-16 |
2008-03-13 |
Abbott Laboratories, Abbott Park |
Verfahren zur herstellung von vernetzten polyallyaminderivaten
|
US6190649B1
(en)
|
1999-04-23 |
2001-02-20 |
Geltex Pharmaceuticals, Inc. |
Polyether-based bile acid sequestrants
|
US6362266B1
(en)
|
1999-09-03 |
2002-03-26 |
The Dow Chemical Company |
Process for reducing cohesiveness of polyallylamine polymer gels during drying
|
US6180754B1
(en)
|
1999-09-03 |
2001-01-30 |
The Dow Chemical Company |
Process for producing cross-linked polyallylamine polymer
|
AU7856200A
(en)
*
|
1999-10-07 |
2001-05-10 |
University Of Maryland |
Sugar binding polymers and the use thereof
|
ATE311203T1
(de)
*
|
1999-10-15 |
2005-12-15 |
Dow Global Technologies Inc |
Dialyselösung die polyglycol als osmotischen mittels enthält
|
US20030202958A1
(en)
*
|
1999-10-15 |
2003-10-30 |
Strickland Alan D. |
Dialysis solution including polyglycol osmotic agent
|
CZ20021344A3
(cs)
*
|
1999-10-19 |
2002-08-14 |
Geltex Pharmaceuticals, Inc. |
Tableta obsahující jádro a potahování a stlačená tableta
|
US6733780B1
(en)
*
|
1999-10-19 |
2004-05-11 |
Genzyme Corporation |
Direct compression polymer tablet core
|
US20020054903A1
(en)
*
|
1999-10-19 |
2002-05-09 |
Joseph Tyler |
Direct compression polymer tablet core
|
WO2001066606A1
(fr)
*
|
2000-03-09 |
2001-09-13 |
Hisamitsu Pharmaceutical Co., Inc. |
Resine echangeuse d'anions reticulee ou sel de celle-ci
|
WO2001066607A1
(fr)
*
|
2000-03-09 |
2001-09-13 |
Hisamitsu Pharmaceutical Co., Inc. |
Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
|
AU2001241095A1
(en)
|
2000-03-13 |
2001-09-24 |
Hisamitsu Pharmaceutical Co. Inc. |
Preventives and/or remedies for hyperphosphatemia
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
WO2002032974A2
(en)
*
|
2000-10-18 |
2002-04-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Polymer and its use for the treatment and/or prevention of hyperphosphoremia
|
JPWO2002043761A1
(ja)
*
|
2000-11-28 |
2004-04-02 |
三菱ウェルファーマ株式会社 |
抗肥満剤及び健康食品
|
ATE473007T1
(de)
*
|
2000-11-28 |
2010-07-15 |
Mitsubishi Tanabe Pharma Corp |
Exkretionsbeschleuniger für eine akkumulative chlorverbindung
|
AT409630B
(de)
*
|
2000-12-13 |
2002-09-25 |
Dsm Fine Chem Austria Gmbh |
Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
|
DE10065710A1
(de)
*
|
2000-12-29 |
2002-07-04 |
Bayer Ag |
Arzneimittel enthaltend ein Polyamin als Wirksubstanz
|
US6710162B2
(en)
|
2001-02-16 |
2004-03-23 |
Genzyme Corporation |
Method of drying a material having a cohesive phase
|
CA2444028A1
(en)
|
2001-04-18 |
2002-10-31 |
Genzyme Corporation |
Methods of treating syndrome x with aliphatic polyamines
|
EP1923064B1
(en)
|
2001-04-18 |
2017-06-28 |
Genzyme Corporation |
Use of amine polymer for lowering serum glucose
|
WO2002085379A1
(en)
*
|
2001-04-18 |
2002-10-31 |
Geltex Pharmaceuticals, Inc. |
Method for improving vascular access in patients with vascular shunts
|
EP1379258B1
(en)
*
|
2001-04-18 |
2006-06-28 |
Genzyme Corporation |
Low salt forms of polyallylamine
|
CA2444046C
(en)
*
|
2001-04-18 |
2011-06-07 |
Steven K. Burke |
Use of colesevelam in reducing serum glucose
|
MX2008011686A
(es)
*
|
2001-05-25 |
2010-05-27 |
Marathon Oil Co |
Inhibicion de sulfuracion del deposito utilizando una inyeccion de agua tratada.
|
US7041280B2
(en)
*
|
2001-06-29 |
2006-05-09 |
Genzyme Corporation |
Aryl boronate functionalized polymers for treating obesity
|
JP2003033651A
(ja)
*
|
2001-07-24 |
2003-02-04 |
Chisso Corp |
経口リン吸着剤及びそれを含む食品
|
CN1270724C
(zh)
|
2001-07-30 |
2006-08-23 |
三菱制药株式会社 |
餐后高血糖改善剂
|
US6600011B2
(en)
|
2001-10-09 |
2003-07-29 |
Genzyme Corporation |
Process for purification and drying of polymer hydrogels
|
FR2833169B1
(fr)
*
|
2001-12-07 |
2004-07-16 |
Oreal |
Composition filtrante contenant un derive de 1,3,5-triazine, un derive du dibenzoylmethane, et un derive de 2-hydroxybenzophenone aminosubstitue
|
US7119120B2
(en)
*
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
ATE337326T1
(de)
*
|
2002-03-19 |
2006-09-15 |
Genzyme Corp |
Hemmer des phosphattransports
|
AT411463B
(de)
|
2002-09-03 |
2004-01-26 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
|
WO2004037274A1
(en)
*
|
2002-10-22 |
2004-05-06 |
Genzyme Corporation |
Amine polymers for promoting bone formation
|
AT412473B
(de)
|
2003-01-15 |
2005-03-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren
|
US7335795B2
(en)
*
|
2004-03-22 |
2008-02-26 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7449605B2
(en)
*
|
2003-11-03 |
2008-11-11 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7767768B2
(en)
*
|
2003-11-03 |
2010-08-03 |
Ilypsa, Inc. |
Crosslinked amine polymers
|
US7385012B2
(en)
|
2003-11-03 |
2008-06-10 |
Ilypsa, Inc. |
Polyamine polymers
|
US7459502B2
(en)
|
2003-11-03 |
2008-12-02 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising crosslinked polyamine polymers
|
US7608674B2
(en)
|
2003-11-03 |
2009-10-27 |
Ilypsa, Inc. |
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
US8426528B2
(en)
*
|
2004-02-23 |
2013-04-23 |
E I Du Pont De Nemours And Company |
Preparation of crosslinked polymers containing biomass derived materials
|
EP1732973A1
(en)
*
|
2004-02-23 |
2006-12-20 |
E.I.Du pont de nemours and company |
Crosslinked polymers containing biomass derived materials
|
CA2560927C
(en)
|
2004-03-26 |
2013-05-14 |
Mitsubishi Pharma Corporation |
Insulin resistance-improving agent
|
EP3574896A1
(en)
|
2004-03-30 |
2019-12-04 |
Relypsa, Inc. |
Ion binding polymers and uses thereof
|
US20050276781A1
(en)
*
|
2004-06-09 |
2005-12-15 |
Ross Edward A |
Molecularly imprinted phosphate binders for therapeutic use
|
WO2006036269A2
(en)
*
|
2004-09-24 |
2006-04-06 |
Biosphere Medical, Inc. |
Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
|
JP2008531751A
(ja)
*
|
2004-10-13 |
2008-08-14 |
イリプサ, インコーポレイテッド |
架橋アミンポリマー
|
US20060177415A1
(en)
*
|
2004-11-01 |
2006-08-10 |
Burke Steven K |
Once a day formulation for phosphate binders
|
US7985418B2
(en)
|
2004-11-01 |
2011-07-26 |
Genzyme Corporation |
Aliphatic amine polymer salts for tableting
|
JP4547620B2
(ja)
*
|
2004-12-02 |
2010-09-22 |
日東紡績株式会社 |
架橋アリルアミン類重合体の製造方法
|
ITME20040015A1
(it)
*
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
EP1830832A1
(en)
*
|
2004-12-30 |
2007-09-12 |
Genzyme Corporation |
Zinc-containing treatments for hyperphosphatemia
|
US20060264672A1
(en)
*
|
2005-02-23 |
2006-11-23 |
Andrews Mark A |
Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers
|
WO2006097942A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Council Of Scientific And Industrial Research |
An improved process for the preparation of crosslinked polyallylamine polymer.
|
AU2006279429B2
(en)
*
|
2005-08-17 |
2010-02-25 |
Hill's Pet Nutrition, Inc. |
Methods and compositions for the prevention and treatment of kidney disease
|
CA2620406A1
(en)
*
|
2005-09-02 |
2007-03-08 |
Genzyme Corporation |
Method for removing phosphate and polymer used therefore
|
AR056499A1
(es)
*
|
2005-09-06 |
2007-10-10 |
Serapis Farmaceuticals Ltd |
Compuestos
|
AU2012205214B2
(en)
*
|
2005-09-15 |
2015-05-21 |
Genzyme Corporation |
Formulation for Amine Polymers
|
EP1924246B1
(en)
*
|
2005-09-15 |
2015-10-21 |
Genzyme Corporation |
Sachet formulation for amine polymers
|
DE112006002618T5
(de)
|
2005-09-30 |
2008-08-28 |
Ilypsa Inc., Santa Clara |
Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers
|
AU2006294455B2
(en)
|
2005-09-30 |
2013-06-20 |
Relypsa, Inc. |
Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
|
WO2007056405A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Genzyme Corporation |
Magnesium-containing polymers for the treatment of hyperphosphatemia
|
EP1973587B1
(en)
*
|
2005-12-12 |
2019-02-06 |
AllAccem, Inc. |
Methods and systems for preparing antimicrobial films and coatings
|
ITRM20060204A1
(it)
*
|
2006-04-10 |
2007-10-11 |
Vincenzo Savica |
Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
|
JP2009536246A
(ja)
*
|
2006-05-05 |
2009-10-08 |
ゲンズイメ コーポレーション |
ホスフェート捕捉剤としてのアミン縮合重合体
|
JP5147695B2
(ja)
|
2006-06-16 |
2013-02-20 |
田辺三菱製薬株式会社 |
糸球体疾患の予防及び/または治療剤
|
JP2009542653A
(ja)
*
|
2006-07-05 |
2009-12-03 |
ジェンザイム コーポレーション |
リン酸塩過剰血症のための鉄(ii)含有治療剤
|
MX2009000611A
(es)
*
|
2006-07-18 |
2009-04-16 |
Genzyme Corp |
Dendrimeros de amina.
|
JP5301273B2
(ja)
|
2006-08-09 |
2013-09-25 |
田辺三菱製薬株式会社 |
錠剤
|
US7964182B2
(en)
*
|
2006-09-01 |
2011-06-21 |
USV, Ltd |
Pharmaceutical compositions comprising phosphate-binding polymer
|
CA2661987C
(en)
*
|
2006-09-01 |
2012-11-06 |
Usv Limited |
Process for the preparation of sevelamer hydrochloride and formulation thereof
|
BRPI0717545A2
(pt)
|
2006-09-29 |
2013-10-22 |
Gezyme Corp |
Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
|
ES2573636T3
(es)
|
2006-10-25 |
2016-06-09 |
Wisconsin Alumni Research Foundation |
Métodos para reducir la absorción de fosfato empleando un anticuerpo anti-Npt2B
|
BRPI0716317A8
(pt)
|
2006-10-26 |
2019-02-05 |
Aovatechnologies Inc |
método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano e método para reduzir a absorção de fosfato em um indivíduo humano
|
JP2010513271A
(ja)
|
2006-12-14 |
2010-04-30 |
ゲンズイメ コーポレーション |
アミド−アミンポリマー組成物
|
JP2008169758A
(ja)
*
|
2007-01-11 |
2008-07-24 |
Bosch Corp |
ターボチャージャ駆動制御方法及びその装置
|
WO2008103847A2
(en)
|
2007-02-21 |
2008-08-28 |
Allaccem, Incorporated |
Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
|
WO2008103368A1
(en)
*
|
2007-02-23 |
2008-08-28 |
Genzyme Corporation |
Amine polymer compositions
|
US20100196305A1
(en)
*
|
2007-03-08 |
2010-08-05 |
Dhal Pradeep K |
Sulfone polymer compositions
|
US8034833B2
(en)
*
|
2008-03-20 |
2011-10-11 |
Biolink Life Sciences, Inc. |
Phosphorus binder for treatment of renal disease
|
JP2010525061A
(ja)
*
|
2007-04-27 |
2010-07-22 |
ゲンズイメ コーポレーション |
アミドアミンデンドリマー組成物
|
JPWO2009008480A1
(ja)
|
2007-07-11 |
2010-09-09 |
東レ株式会社 |
架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
|
EP2016947A1
(en)
*
|
2007-07-17 |
2009-01-21 |
Chemo Ibérica, S.A. |
Novel one step process for preparing cross-linked poly(allylamine) polymers
|
WO2009023544A2
(en)
*
|
2007-08-10 |
2009-02-19 |
Ilypsa, Inc. |
Dosage unit anion-exchange polymer pharmaceutical compositions
|
US8153617B2
(en)
*
|
2007-08-10 |
2012-04-10 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for coating oral surfaces in humans
|
US8188068B2
(en)
*
|
2007-08-10 |
2012-05-29 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for coating oral surfaces in pets
|
US8153618B2
(en)
*
|
2007-08-10 |
2012-04-10 |
Allaccem, Inc. |
Bridged polycyclic compound based compositions for topical applications for pets
|
US20090074833A1
(en)
*
|
2007-08-17 |
2009-03-19 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for controlling bone resorption
|
TWI468167B
(zh)
|
2007-11-16 |
2015-01-11 |
威佛(國際)股份有限公司 |
藥學組成物
|
EP2217215A1
(en)
*
|
2007-12-14 |
2010-08-18 |
Genzyme Corporation |
Coated pharmaceutical compositions
|
US8389640B2
(en)
*
|
2008-04-15 |
2013-03-05 |
Lupin Limited |
Process for the preparation of cross-linked polyallylamine polymer
|
US20110142952A1
(en)
*
|
2008-06-20 |
2011-06-16 |
Harris David J |
Pharmaceutical Compositions
|
US20100016270A1
(en)
*
|
2008-06-20 |
2010-01-21 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for controlling cholesterol levels
|
US20100004218A1
(en)
*
|
2008-06-20 |
2010-01-07 |
Whiteford Jeffery A |
Bridged polycyclic compound based compositions for renal therapy
|
DE102008030046A1
(de)
|
2008-06-25 |
2009-12-31 |
Ratiopharm Gmbh |
Kompaktiertes Polyallylamin-Polymer
|
US8404784B2
(en)
*
|
2008-12-03 |
2013-03-26 |
Navinta Llc |
Manufacturing process of making polymeric amine salts
|
US20100166861A1
(en)
*
|
2008-12-29 |
2010-07-01 |
Kelly Noel Lynch |
Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
|
WO2010086881A2
(en)
|
2009-01-22 |
2010-08-05 |
Usv Limited |
Pharmaceutical compositions comprising phosphate-binding polymer
|
CA2765370A1
(en)
|
2009-06-16 |
2010-12-23 |
Watson Pharma Private Limited |
Processes for the preparation of sevelamer carbonate
|
US8673272B2
(en)
*
|
2009-07-27 |
2014-03-18 |
Isp Investments Inc. |
Ultraviolet-absorbing compounds
|
JP5377265B2
(ja)
*
|
2009-12-16 |
2013-12-25 |
一般財団法人川村理化学研究所 |
ポリマー/酒石酸結晶性ナノ複合体及びその製造方法
|
GB0921951D0
(en)
*
|
2009-12-16 |
2010-02-03 |
Fujifilm Mfg Europe Bv |
Curable compositions and membranes
|
US8951177B2
(en)
|
2010-01-15 |
2015-02-10 |
Graphic Packaging International, Inc. |
Flight lug for octagonal cartons
|
JP5865847B2
(ja)
|
2010-02-24 |
2016-02-17 |
レリプサ, インコーポレイテッド |
胆汁酸捕捉剤として使用するための架橋されたポリビニルアミン、ポリアリルアミンおよびポリエチレンイミン
|
JP5717422B2
(ja)
*
|
2010-11-30 |
2015-05-13 |
株式会社パイロットコーポレーション |
ゲル状組成物の製造方法
|
IT1404163B1
(it)
*
|
2011-02-01 |
2013-11-15 |
Chemi Spa |
Processo per la preparazione di poliallilamine reticolate o loro sali farmaceuticamente accettabili
|
ES2563316T3
(es)
|
2011-02-09 |
2016-03-14 |
Synthon Bv |
Formas estabilizadas de envasado de sevelamer
|
CN102796262B
(zh)
*
|
2011-05-24 |
2014-11-12 |
北大方正集团有限公司 |
一种碳酸司维拉姆的制备方法
|
EP2773329B1
(en)
|
2011-11-04 |
2016-01-13 |
Synthon BV |
Pharmaceutical compositions comprising sevelamer
|
US20130123433A1
(en)
|
2011-11-14 |
2013-05-16 |
Formosa Laboratories, Inc. |
Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
|
RU2014128587A
(ru)
|
2011-12-13 |
2016-02-10 |
Синтон Б.В. |
Получение севеламера с пониженным содержанием аллиламина
|
WO2013087237A1
(en)
|
2011-12-13 |
2013-06-20 |
Synthon Bv |
Purification of sevelamer and related polyallylamines
|
CN102675510B
(zh)
*
|
2012-05-28 |
2014-04-02 |
诚达药业股份有限公司 |
司维拉姆的合成工艺
|
ES2471340B1
(es)
|
2012-12-21 |
2015-08-17 |
Laboratorios Rubió, S.A. |
Composición farmacéutica oral para fármacos de elevada posología
|
CN105263477B
(zh)
|
2013-03-13 |
2019-01-15 |
生物领域医疗公司 |
用于放射性同位素结合微粒的组合物和相关方法
|
CN103446179B
(zh)
*
|
2013-05-14 |
2017-03-15 |
厦门绿洲安源投资管理有限公司 |
作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
|
EP3287133B1
(en)
|
2013-06-05 |
2019-04-17 |
Tricida Inc. |
Proton-binding polymers for oral administration
|
JP6903576B2
(ja)
|
2014-12-10 |
2021-07-14 |
トリシダ・インコーポレイテッドTricida, Inc. |
経口投与用プロトン結合ポリマー
|
MA41202A
(fr)
|
2014-12-18 |
2017-10-24 |
Genzyme Corp |
Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
|
CN107530370B
(zh)
|
2015-03-20 |
2021-01-26 |
杨达志 |
用于培养哺乳动物细胞的微载体、基质和支架及其制造方法
|
WO2016150341A1
(zh)
|
2015-03-20 |
2016-09-29 |
杨达志 |
多糖-聚氨共聚物及其在降低血浆中尿酸浓度的应用
|
US10245284B2
(en)
|
2015-08-19 |
2019-04-02 |
Alpex Pharma S.A. |
Granular composition for oral administration
|
CN109153587A
(zh)
|
2016-03-08 |
2019-01-04 |
技术研究及发展基金有限公司 |
来自盐水水产养殖系统的氮物质的消毒和去除
|
CN109414453B
(zh)
|
2016-05-06 |
2023-02-17 |
特里赛达公司 |
用于治疗酸碱失衡的组合物
|
BR112019013364A2
(pt)
|
2016-12-28 |
2020-04-14 |
Fujifilm Corp |
emulsão de polímero contendo átomo de nitrogênio ou sal do mesmo, método de produção para o mesmo e método de produção para partículas
|
CN107412166B
(zh)
*
|
2017-08-08 |
2020-03-24 |
同济大学 |
一种纳米复合吸附磷材料及其制备与应用
|
US10934380B1
(en)
|
2017-09-25 |
2021-03-02 |
Tricida, Inc. |
Crosslinked poly(allylamine) polymer pharmaceutical compositions
|
EP3698799B1
(en)
*
|
2017-10-16 |
2022-01-26 |
FUJIFILM Corporation |
Hyperphosphatemia treatment agent
|
CA3079171C
(en)
|
2017-10-16 |
2023-09-12 |
Fujifilm Corporation |
Therapeutic agent for hyperphosphatemia and particles
|
US10479865B2
(en)
|
2017-11-01 |
2019-11-19 |
Strides Shasun Limited |
Process for the preparation of sevelamer carbonate
|
US11266684B2
(en)
|
2017-11-03 |
2022-03-08 |
Tricida, Inc. |
Compositions for and method of treating acid-base disorders
|
CN112047854B
(zh)
*
|
2020-10-20 |
2021-07-02 |
中国科学院长春应用化学研究所 |
一种n-乙烯基烷基酰胺的制备方法
|
EP4295836A1
(en)
|
2022-06-22 |
2023-12-27 |
Labomed Pharmaceutical Company S.A. |
Sachet comprising a liquid suspension of a sevelamer salt
|
WO2024084076A1
(en)
*
|
2022-10-20 |
2024-04-25 |
Universiteit Gent |
Method to prepare amidated polymers
|